190 related articles for article (PubMed ID: 26351212)
41. The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis.
Demidov ON; Kek C; Shreeram S; Timofeev O; Fornace AJ; Appella E; Bulavin DV
Oncogene; 2007 Apr; 26(17):2502-6. PubMed ID: 17016428
[TBL] [Abstract][Full Text] [Related]
42. WIP1, a homeostatic regulator of the DNA damage response, is targeted by HIPK2 for phosphorylation and degradation.
Choi DW; Na W; Kabir MH; Yi E; Kwon S; Yeom J; Ahn JW; Choi HH; Lee Y; Seo KW; Shin MK; Park SH; Yoo HY; Isono K; Koseki H; Kim ST; Lee C; Kwon YK; Choi CY
Mol Cell; 2013 Aug; 51(3):374-85. PubMed ID: 23871434
[TBL] [Abstract][Full Text] [Related]
43. Phosphatase Wip1 negatively regulates neutrophil development through p38 MAPK-STAT1.
Liu G; Hu X; Sun B; Yang T; Shi J; Zhang L; Zhao Y
Blood; 2013 Jan; 121(3):519-29. PubMed ID: 23212517
[TBL] [Abstract][Full Text] [Related]
44. Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity.
Sriraman A; Radovanovic M; Wienken M; Najafova Z; Li Y; Dobbelstein M
Oncotarget; 2016 May; 7(22):31623-38. PubMed ID: 27183917
[TBL] [Abstract][Full Text] [Related]
45. NF-κB-induced WIP1 expression promotes colorectal cancer cell proliferation through mTOR signaling.
Bai F; Zhou H; Fu Z; Xie J; Hu Y; Nie S
Biomed Pharmacother; 2018 Mar; 99():402-410. PubMed ID: 29367109
[TBL] [Abstract][Full Text] [Related]
46. [Inhibition of WIP1 in A549 cells enhances the sensitivity of cells to arsenic treatment].
Luo Q; Gu S; Zhang Z
Wei Sheng Yan Jiu; 2017 May; 46(3):389-395. PubMed ID: 29903248
[TBL] [Abstract][Full Text] [Related]
47. Wip1 cooperates with KPNA2 to modulate the cell proliferation and migration of colorectal cancer via a p53-dependent manner.
Wang P; Zhao Y; Liu K; Liu X; Liang J; Zhou H; Wang Z; Zhou Z; Xu N
J Cell Biochem; 2019 Sep; 120(9):15709-15718. PubMed ID: 31127650
[TBL] [Abstract][Full Text] [Related]
48. DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase.
Brazina J; Svadlenka J; Macurek L; Andera L; Hodny Z; Bartek J; Hanzlikova H
Cell Cycle; 2015; 14(3):375-87. PubMed ID: 25659035
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1.
Lin J; Zhang Q; Lu Y; Xue W; Xu Y; Zhu Y; Hu X
PLoS One; 2014; 9(5):e98418. PubMed ID: 24846322
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC.
Yang S; Dong S; Qu X; Zhong X; Zhang Q
Mol Med Rep; 2017 Feb; 15(2):719-723. PubMed ID: 27959454
[TBL] [Abstract][Full Text] [Related]
51. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.
Fujimoto H; Onishi N; Kato N; Takekawa M; Xu XZ; Kosugi A; Kondo T; Imamura M; Oishi I; Yoda A; Minami Y
Cell Death Differ; 2006 Jul; 13(7):1170-80. PubMed ID: 16311512
[TBL] [Abstract][Full Text] [Related]
52. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D.
Castellino RC; De Bortoli M; Lu X; Moon SH; Nguyen TA; Shepard MA; Rao PH; Donehower LA; Kim JY
J Neurooncol; 2008 Feb; 86(3):245-56. PubMed ID: 17932621
[TBL] [Abstract][Full Text] [Related]
53. Induction of breast cancer in wild type p53 cells by BRCA1-IRIS overexpression.
Elshamy WM
Hawaii Med J; 2010 Aug; 69(8):200-1. PubMed ID: 20845286
[TBL] [Abstract][Full Text] [Related]
54. Expression of Wip1 in kidney carcinoma and its correlation with tumor metastasis and clinical significance.
Sun GG; Wang YD; Liu Q; Hu WN
Pathol Oncol Res; 2015 Jan; 21(1):219-24. PubMed ID: 24970693
[TBL] [Abstract][Full Text] [Related]
55. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
Kang YH; Lee SJ
J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
[TBL] [Abstract][Full Text] [Related]
56. Wip1-dependent signaling pathways in health and diseases.
Zhu YH; Bulavin DV
Prog Mol Biol Transl Sci; 2012; 106():307-25. PubMed ID: 22340722
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells.
Chen L; Mayer JA; Krisko TI; Speers CW; Wang T; Hilsenbeck SG; Brown PH
Cancer Res; 2009 Dec; 69(23):8853-61. PubMed ID: 19920204
[TBL] [Abstract][Full Text] [Related]
58. Activation of Bak and Bax through c-abl-protein kinase Cdelta-p38 MAPK signaling in response to ionizing radiation in human non-small cell lung cancer cells.
Choi SY; Kim MJ; Kang CM; Bae S; Cho CK; Soh JW; Kim JH; Kang S; Chung HY; Lee YS; Lee SJ
J Biol Chem; 2006 Mar; 281(11):7049-59. PubMed ID: 16410245
[TBL] [Abstract][Full Text] [Related]
59. The HBP1 transcriptional repressor participates in RAS-induced premature senescence.
Zhang X; Kim J; Ruthazer R; McDevitt MA; Wazer DE; Paulson KE; Yee AS
Mol Cell Biol; 2006 Nov; 26(22):8252-66. PubMed ID: 16966377
[TBL] [Abstract][Full Text] [Related]
60. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner.
Fiscella M; Zhang H; Fan S; Sakaguchi K; Shen S; Mercer WE; Vande Woude GF; O'Connor PM; Appella E
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6048-53. PubMed ID: 9177166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
